Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease.-Reference-Cited by-同舟云学术

Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease.

Published:1990-07-14 Issue:6743 Volume:301 Page:97-97
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Lavelle-Jones M,al-Hadrani A,Spiers E M,Campbell F C,Cuschieri A

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference5 articles.

1. Lymphokine activated killer cell activity in rheumatoid arthritis;Jira, M.; Malkovsky, M.; Denmen, A.M.;Clin Exp Immunol,1987

2. Lymphapheresis in rheumatoid arthritis;Karsh, J.; Klippel, J.H.; Plotz, P.H.;Arthritis Rheum,1981

3. Detection of activated T cell products in the rheumatic joint using cDNA probes to interleuikin-2 (IL-2) receptor and IFN-gamma. Clin Exp Immunol;Buchan, G.; Barrett, K.; Fujita, T.,1988

4. Weiss A. T lymphocytes. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook ofrheumatology. Philadelphia: W B Saunders, 1989:148-61.

5. Ibuprofen causes reduced toxic effects of interleukin 2 administration in patients with metastatic cancer;Eberlein, T.J.; Schoof, D.D.; Michie, H.R.;Arch Surg,1989

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous analysis of T cell clonality and cytokine production in rheumatoid arthritis using three-colour flow cytometry;Clinical and Experimental Immunology;2002-08

2. Manifestations rhumatologiques des anticancéreux;Revue du Rhumatisme;2002-04

3. Functional IL-2 Receptor β (CD122) and γ (CD132) Chains Are Expressed by Fibroblast-Like Synoviocytes: Activation by IL-2 Stimulates Monocyte Chemoattractant Protein-1 Production;The Journal of Immunology;2001-03-15

4. SELECTED DRUG COMPLICATIONS AND TREATMENT CONFLICTS IN THE PRESENCE OF COEXISTENT DISEASES;Rheumatic Disease Clinics of North America;1999-08

5. Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.;Journal of Neurology, Neurosurgery & Psychiatry;1997-01-01